These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30455316)

  • 1. Probabilistic control of HIV latency and transactivation by the Tat gene circuit.
    Cao Y; Lei X; Ribeiro RM; Perelson AS; Liang J
    Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12453-12458. PubMed ID: 30455316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
    Chakraborty S; Kabi M; Ranga U
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV latency reversing agents act through Tat post translational modifications.
    Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
    Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The viral protein Tat can inhibit the establishment of HIV-1 latency.
    Donahue DA; Kuhl BD; Sloan RD; Wainberg MA
    J Virol; 2012 Mar; 86(6):3253-63. PubMed ID: 22238306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
    Wilhelm E; Poirier M; Da Rocha M; Bédard M; McDonald PP; Lavigne P; Hunter CL; Bell B
    PLoS Pathog; 2024 May; 20(5):e1011821. PubMed ID: 38781120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the identification of Tat-mediated transactivation inhibitors: progressing toward a functional cure of HIV.
    Tabarrini O; Desantis J; Massari S
    Future Med Chem; 2016; 8(4):421-42. PubMed ID: 26933891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Tat endocytosis and retention in endolysosomes affects HIV-1 Tat-induced LTR transactivation in astrocytes.
    Khan N; Halcrow PW; Afghah Z; Baral A; Geiger JD; Chen X
    FASEB J; 2022 Mar; 36(3):e22184. PubMed ID: 35113458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.
    Mbonye U; Karn J
    Virology; 2014 Apr; 454-455():328-39. PubMed ID: 24565118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
    Jin H; Li D; Lin MH; Li L; Harrich D
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32276443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of HIV latency.
    Cary DC; Fujinaga K; Peterlin BM
    J Clin Invest; 2016 Feb; 126(2):448-54. PubMed ID: 26731470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-viral opportunities during transcriptional activation of latent HIV in the host chromatin.
    Mujtaba S; Zhou MM
    Methods; 2011 Jan; 53(1):97-101. PubMed ID: 20828615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lost in transcription: molecular mechanisms that control HIV latency.
    Taube R; Peterlin M
    Viruses; 2013 Mar; 5(3):902-27. PubMed ID: 23518577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
    Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
    Rice AP
    Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
    Mousseau G; Valente ST
    Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.